Stay updated on SAR442257 Clinical Trial in RRMM & RR-NHL
Sign up to get notified when there's something new on the SAR442257 Clinical Trial in RRMM & RR-NHL page.

Latest updates to the SAR442257 Clinical Trial in RRMM & RR-NHL page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check14 days agoChange DetectedThe record history indicates that references were added to the study record in May 2026. A site-wide notice also announces NIH terminology changes from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check21 days agoChange DetectedThe ClinicalTrials.gov site revision displayed in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedA new study-record version dated 2026-09-29 was added, updating the study identification and status. The record now lists the trial as terminated, citing limited clinical benefit in both the multiple myeloma and non-Hodgkin lymphoma cohorts.SummaryDifference0.3%

- Check49 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, replacing the previous v3.6.6. This indicates an update to the page's version in the history log.SummaryDifference0.1%

Stay in the know with updates to SAR442257 Clinical Trial in RRMM & RR-NHL
Enter your email address, and we'll notify you when there's something new on the SAR442257 Clinical Trial in RRMM & RR-NHL page.